Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with limited treatment options in the advanced stages. Immunotherapy offers hope for altering the orthodox management of cancer, and its role in advanced ACC has been investigated in different studies. With the aim clarifying the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Araujo-Castro, Marta, Pascual-Corrales, Eider, Molina-Cerrillo, Javier, Alonso-Gordoa, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002272/
https://www.ncbi.nlm.nih.gov/pubmed/33809752
http://dx.doi.org/10.3390/biomedicines9030304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002272/
https://www.ncbi.nlm.nih.gov/pubmed/33809752
http://dx.doi.org/10.3390/biomedicines9030304

Ejemplares similares